Literature DB >> 3921861

Lipoxygenase products of arachidonic acid stimulate LHRH release from rat median eminence.

K Gerozissis, B Vulliez, J M Saavedra, R C Murphy, F Dray.   

Abstract

Exogenous arachidonic acid (AA) incubated in presence of male rat hypothalamus, shows a low rate of conversion (less than 1%) of the substrate with a major product, identified as 12-hydroxyeicosatetraenoic acid (12-HETE) by reverse phase-high performance liquid chromatography (rpHPLC) and gas chromatography-mass spectrometry (GC-MS). Furthermore, immunoreactive 12-HETE estimated after purification on rpHPLC is produced by hypothalamus slices or median eminences (MEs) incubated in absence of any exogenous precursor. The effect of 12-HETE was tested on the release of LHRH from rat MEs after a 30-min incubation and was compared to the effect of another lipoxygenase product, 5-HETE, and to the well-known stimulatory effect of prostaglandin E2 (PGE2). The three AA metabolites stimulate LHRH release. A significant stimulatory effect on LHRH release is obtained with 10(-9) M of 12-HETE and only with 10(-8) M of 5-HETE or PGE2. Furthermore, the effect of higher concentrations is different according to the eicosanoid tested. The maximal response (176% of the control) is reached with 12-HETE at 10(-8) M. No significant change is observed at 10(-7) and 10(-6) M. The response with 5-HETE is also maximal (162% of the control) at 10(-8) M but decreases significantly (only 117% of the control) at 10(-6) M. The amplitude of the response to PGE2 is larger and higher, reaching a plateau (300% of the control) at 10(-6) M. 12-HETE has no effect on somatostatin (SRIF), release, as already known for PGE2.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921861     DOI: 10.1159/000124084

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  3 in total

1.  Possible involvement of lipoxygenase pathway of arachidonic acid in rat pituitary hormone release in vitro.

Authors:  A Miyake; T Nishizaki; H Ikegami; K Koike; K Hirota; O Tanizawa
Journal:  J Endocrinol Invest       Date:  1988-12       Impact factor: 4.256

2.  Specific delta-opioid antagonists exert an agonist-independent inhibitory effect, similar to the agonist, on the release of GnRH in vitro.

Authors:  I Dragatsis; C Zioudrou; K Gerozissis
Journal:  Cell Mol Neurobiol       Date:  1995-08       Impact factor: 5.046

3.  Brain 12-HETE formation in different species, brain regions, and in brain microvessels.

Authors:  G S Hambrecht; S A Adesuyi; S Holt; E F Ellis
Journal:  Neurochem Res       Date:  1987-11       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.